193 related articles for article (PubMed ID: 35526305)
1. Prognostic value of integrin αV expression and localization pattern in invasive breast carcinomas.
Cerqueira OLD; Botelho MCS; Fiore APZP; Osório CABT; Tomasin R; Morais MCC; López RVM; Cardoso EC; Vilella-Arias SA; Reis EM; Bruni-Cardoso A
Neoplasia; 2022 Aug; 30():100803. PubMed ID: 35526305
[TBL] [Abstract][Full Text] [Related]
2. Genetic depletion and pharmacological targeting of αv integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models.
Li Y; Drabsch Y; Pujuguet P; Ren J; van Laar T; Zhang L; van Dam H; Clément-Lacroix P; Ten Dijke P
Breast Cancer Res; 2015 Feb; 17(1):28. PubMed ID: 25849225
[TBL] [Abstract][Full Text] [Related]
3. αv-Integrin isoform expression in primary human tumors and brain metastases.
Vogetseder A; Thies S; Ingold B; Roth P; Weller M; Schraml P; Goodman SL; Moch H
Int J Cancer; 2013 Nov; 133(10):2362-71. PubMed ID: 23661241
[TBL] [Abstract][Full Text] [Related]
4. Interactions between αv-Integrin and HER2 and Their Role in the Invasive Phenotype of Breast Cancer Cells In Vitro and in Rat Brain.
Lal S; Kersch C; Beeson KA; Wu YJ; Muldoon LL; Neuwelt EA
PLoS One; 2015; 10(7):e0131842. PubMed ID: 26222911
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of integrin αv in the human nasopharyngeal carcinoma associated with metastasis and progression.
Xuan SH; Zhou YG; Pan JQ; Zhu W; Xu P
Cancer Biomark; 2013; 13(5):323-8. PubMed ID: 24440971
[TBL] [Abstract][Full Text] [Related]
6. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
7. AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients.
Davidson B; Goldberg I; Reich R; Tell L; Dong HP; Trope' CG; Risberg B; Kopolovic J
Gynecol Oncol; 2003 Aug; 90(2):248-57. PubMed ID: 12893184
[TBL] [Abstract][Full Text] [Related]
8. αvβ1 integrin is enriched in extracellular vesicles of metastatic breast cancer cells: A mechanism mediated by galectin-3.
Zhang DX; Dang XTT; Vu LT; Lim CMH; Yeo EYM; Lam BWS; Leong SM; Omar N; Putti TC; Yeh YC; Ma V; Luo JY; Cho WC; Chen G; Lee VKM; Grimson A; Le MTN
J Extracell Vesicles; 2022 Aug; 11(8):e12234. PubMed ID: 35923105
[TBL] [Abstract][Full Text] [Related]
9. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
[TBL] [Abstract][Full Text] [Related]
10. Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.
dos Santos PB; Zanetti JS; Ribeiro-Silva A; Beltrão EI
Diagn Pathol; 2012 Aug; 7():104. PubMed ID: 22894137
[TBL] [Abstract][Full Text] [Related]
11. alphaV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma.
Koistinen P; Ahonen M; Kähäri VM; Heino J
Int J Cancer; 2004 Oct; 112(1):61-70. PubMed ID: 15305376
[TBL] [Abstract][Full Text] [Related]
12. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin is associated with decreased apoptosis and αv integrin expression in lung adenocarcinoma.
Štemberger C; Matušan-Ilijaš K; Avirović M; Bulat-Kardum L; Ivančić A; Jonjić N; Lučin K
Acta Histochem; 2014 Jan; 116(1):222-9. PubMed ID: 23992637
[TBL] [Abstract][Full Text] [Related]
14. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
15. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
16. High αv Integrin Level of Cancer Cells Is Associated with Development of Brain Metastasis in Athymic Rats.
Wu YJ; Pagel MA; Muldoon LL; Fu R; Neuwelt EA
Anticancer Res; 2017 Aug; 37(8):4029-4040. PubMed ID: 28739685
[TBL] [Abstract][Full Text] [Related]
17. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of αvβ6 integrin in DCIS identifies high-risk patients and predicts recurrence.
Allen MD; Thomas GJ; Clark S; Dawoud MM; Vallath S; Payne SJ; Gomm JJ; Dreger SA; Dickinson S; Edwards DR; Pennington CJ; Sestak I; Cuzick J; Marshall JF; Hart IR; Jones JL
Clin Cancer Res; 2014 Jan; 20(2):344-57. PubMed ID: 24150233
[TBL] [Abstract][Full Text] [Related]
18. Integrin chains beta1 and alphav as prognostic factors in human metastatic melanoma.
Nikkola J; Vihinen P; Vlaykova T; Hahka-Kemppinen M; Heino J; Pyrhönen S
Melanoma Res; 2004 Feb; 14(1):29-37. PubMed ID: 15091191
[TBL] [Abstract][Full Text] [Related]
19. Analysis of αv integrin protein expression in human eyelid and periorbital squamous cell carcinomas.
Hsu A; Esmaeli B; Hayek B; Hossain MG; Shinder R; Lazar AJ; McCarty JH
J Cutan Pathol; 2011 Jul; 38(7):570-5. PubMed ID: 21375561
[TBL] [Abstract][Full Text] [Related]
20. Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Ciardiello C; Leone A; Lanuti P; Roca MS; Moccia T; Minciacchi VR; Minopoli M; Gigantino V; De Cecio R; Rippa M; Petti L; Capone F; Vitagliano C; Milone MR; Pucci B; Lombardi R; Iannelli F; Di Gennaro E; Bruzzese F; Marchisio M; Carriero MV; Di Vizio D; Budillon A
J Exp Clin Cancer Res; 2019 Jul; 38(1):317. PubMed ID: 31319863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
